Spine Surgery, Nanoori Gangnam Hospital, Seoul 06048, Korea.
Orthopaedic Surgery, Jurong Health Campus, National University Health Systems, Singapore 119228, Singapore.
Int J Mol Sci. 2020 Mar 20;21(6):2135. doi: 10.3390/ijms21062135.
With an aging population, there is a proportional increase in the prevalence of intervertebral disc diseases. Intervertebral disc diseases are the leading cause of lower back pain and disability. With a high prevalence of asymptomatic intervertebral disc diseases, there is a need for accurate diagnosis, which is key to management. A thorough understanding of the pathophysiology and clinical manifestation aids in understanding the natural history of these conditions. Recent developments in radiological and biomarker investigations have potential to provide noninvasive alternatives to the gold standard, invasive discogram. There is a large volume of literature on the management of intervertebral disc diseases, which we categorized into five headings: (a) Relief of pain by conservative management, (b) restorative treatment by molecular therapy, (c) reconstructive treatment by percutaneous intervertebral disc techniques, (d) relieving compression and replacement surgery, and (e) rigid fusion surgery. This review article aims to provide an overview on various current diagnostic and treatment options and discuss the interplay between each arms of these scientific and treatment advancements, hence providing an outlook of their potential future developments and collaborations in the management of intervertebral disc diseases.
随着人口老龄化,椎间盘疾病的患病率呈比例增加。椎间盘疾病是导致下腰痛和残疾的主要原因。由于无症状椎间盘疾病的患病率较高,因此需要进行准确的诊断,这是管理的关键。深入了解其病理生理学和临床表现有助于了解这些疾病的自然病程。放射学和生物标志物研究的最新进展有可能为金标准(即有创椎间盘造影术)提供非侵入性替代方法。关于椎间盘疾病的治疗有大量文献,我们将其分为五个标题:(a)通过保守治疗缓解疼痛,(b)通过分子治疗进行修复治疗,(c)通过经皮椎间盘技术进行重建治疗,(d)缓解压迫和置换手术,以及(e)刚性融合手术。本文旨在对各种当前的诊断和治疗选择进行综述,并讨论这些科学和治疗进展之间的相互作用,从而展望它们在椎间盘疾病治疗中的潜在未来发展和合作。